David McIntosh: UK Plasma Action – a Founder’s Reflections
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
”UK Plasma Action – a Founder’s Reflections
The UKPA campaign, launched in June 2019, was aimed at the discontinuation of a 23 year-old ban on the pharmaceutical use of UK donors’ plasma.
Much has happened since then and much good work has been done. Our donations are once again contributing to the manufacture of some vital plasma-derived medicines. The worst of the waste has been halted.
However, it seems appropriate, seven years on, to pause and reflect on the progress made so far – and the extent to which more action is still required.
The 20th Century fears about alleged risks of Variant Creutzfeldt Jakob disease in this context have now finally been dispelled.
However, the full Regulatory consequences and Healthcare gains from this welcome development are yet to be realised.
There is unfinished business here…….”
Other posts featuring David McIntosh on Hemostasis Today.
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?